lobbying_activities: 3480381

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3480381	d3750953-345a-45d3-a4da-197d55f328b2	Q4	TRUSYNERGY	401107715	BURRELL INTERNATIONAL GROUP LLC (ON BEHALF OF SHIONOGI INC.)	2025	fourth_quarter	PHA	Funding for the SNS, BARDA, and IBMSC; promoting safer and more effective treatments in the stockpile; promoting onshoring and domestic manufacturing of medicines and their components; prioritizing investments in more effective treatments to combat AMR; PASTEUR Act; reauthorization of the Pandemic and All Hazards Preparedness Act; funding and incentives for MCM development; AMR issues; development of infectious disease and AMR treatments; FY 26 LHHS appropriations; Rare Pediatric Disease Priority Review Voucher; MFN drug pricing; tariffs	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2026-01-09T17:12:20-05:00